Goessl, Carsten
GlaxoSmithKline, USA,
United States
2025 Rank: 165602
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1701 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165602 | 187358 |
| Total Cites | 9707 | 10436 |
| H-index | 31 | 31 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 44 | 45 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 1084 | 1138 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 3983 | 4284 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7944 | 8368 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
6.99%
|
|
Goessl, Carsten
GlaxoSmithKline, USA,
United States
2024 Rank: 159031
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1665 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159031 | 180283 |
| Total Cites | 8684 | 9354 |
| H-index | 30 | 30 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 44 | 45 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 1072 | 1126 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 3842 | 4137 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7082 | 7467 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
7.16%
|
|
Goessl, Carsten
AstraZeneca,
United Kingdom
2023 Rank: 154070
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1627 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 154070 | 174050 |
| Total Cites | 7530 | 8140 |
| H-index | 30 | 30 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 42 | 43 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 1056 | 1110 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 3663 | 3959 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6140 | 6485 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
7.49%
|
|
Goessl, Carsten
AstraZeneca,
United States
2022 Rank: 148689
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1571 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148689 | 166109 |
| Total Cites | 6333 | 6879 |
| H-index | 28 | 29 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 41 | 42 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1044 | 1102 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 3444 | 3739 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5174 | 5485 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
7.94%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.